A Phase II, Randomized, Double-blind, 2-Part, Multicenter Study To Compare the Efficacy of ZD6474 with the Efficacy of ZD1839 (Iressa) in Patients With Locally Advanced or Metastatic (IIIB/IV) Non-small Cell Lung Cancer after Failure of either First-Line and/or Second-line Platinum-based Chemotherapy and to Assess the Activity of ZD6474 in Patients Following Failure of Treatment With ZD1839
Study identifier:D4200C00003
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase II, Randomized, Double-blind, 2-Part, Multicenter Study To Compare the Efficacy of ZD6474 with the Efficacy of ZD1839 (Iressa) in Patients With Locally Advanced or Metastatic (IIIB/IV) Non-small Cell Lung Cancer after Failure of either First-Line and/or Second-line Platinum-based Chemotherapy and to Assess the Activity of ZD6474 in Patients Following Failure of Treatment With ZD1839
Medical condition
solid tumour
Phase
Phase 2
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 May 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
